Prospective molecular monitoring of minimal residual disease after non-myeloablative allografting in newly diagnosed multiple myelomaMarco Ladetto, Benedetto Bruno, Simone Ferrero et al.|Leukemia|2015Cited by 36
Survival improvement of poor-prognosis AML/MDS patients by maintenance treatment with low-dose chemotherapy and differentiating agentsDario Ferrero, Mario Boccadoro, Chiara Frairia et al.|Annals of Hematology|2014Cited by 31
Multicenter Experience Using Total Lymphoid Irradiation and Antithymocyte Globulin as Conditioning for Allografting in Hematological MalignanciesGiuseppe Messina, Benedetto Bruno, Luisa Giaccone et al.|Biology of Blood and Marrow Transplantation|2012Cited by 30
Allogeneic Hematopoietic Cell Transplantation from Unrelated Donors in Multiple Myeloma: Study from the Italian Bone Marrow Donor RegistryRoberto Passera, Benedetto Bruno, Simona Pollichieni et al.|Biology of Blood and Marrow Transplantation|2013Cited by 21
Hematopoietic cell transplantation comorbidity index and risk of developing invasive fungal infections after allograftingAlessandro Busca, Benedetto Bruno, Roberto Passera et al.|Bone Marrow Transplantation|2018Cited by 17